Articles from Sheridan Capital Partners

Sheridan Capital Partners (“Sheridan”) today announced the completion of its investment in Currier Plastics (“Currier” or “the Company”), a manufacturer of custom, precision plastic components used primarily in healthcare and life sciences. The investment reflects Sheridan’s continued evolution as a healthcare investor with expertise in multiple sectors across the healthcare landscape, from outsourced services and medical products to software and technology for providers, payors and pharma. Concurrently with the closing of the investment, the Company announced that Andrew McLean has been named the Company’s new CEO.

Sheridan Capital Partners (“Sheridan”) today announced the completion of its investment in National Care Systems (“NCS” or the “Company”), a provider of revenue cycle management (“RCM”) software serving skilled nursing facilities (“SNFs”) and assisted living facilities (“ALFs”) across the United States.

Sheridan Capital Partners (“Sheridan”) today announced the majority sale of DAS Health Ventures, LLC (“DAS Health” or “the Company”), a provider of healthcare IT and business solutions, to Coalesce Capital. Sheridan initially partnered with DAS Health in 2021 and will retain a minority ownership position following the transaction.

Sheridan Capital Partners (“SCP”) partnered with Future Care Consultants (“FCC”, now branded as Focal Point Care “FPC”), a specialty revenue cycle management and technology-enabled back-office outsourced services provider to the skilled nursing facility (“SNF”) market, in January 2023. Over the past two years, the company has undergone rapid transformation, evolving into a provider of end-to-end solutions for skilled nursing facilities and offering critical support to facilities nationwide.

Oral Surgery Partners (“OSP”), an established oral surgery management group, is pleased to announce the appointment of Sohail Malad as its new Chief Executive Officer, effective August 12th. Sohail Malad, a seasoned healthcare executive with a proven track record of leadership and innovation, will succeed John Cline, who served as CEO for the past three years and will continue to remain involved in an advisory capacity. Under John’s tenure, OSP experienced significant growth, establishing itself as a trusted name in the oral surgery field, and his continued involvement will ensure a smooth and effective leadership transition.

Oral Surgery Partners (“OSP”) announced today the closing of a $75 million credit expansion. The facility expansion was provided by the existing lending partners and will allow OSP to continue to grow through 2024 and beyond.

Oral Surgery Partners (“OSP”), an established and rapidly-growing oral surgery management group backed by Sheridan Capital Partners (“SCP”), announced today the closing of a $400+ million credit expansion to build on existing success in partnership with funds managed by Neuberger Berman and Aquarian Investments. With this additional capital, OSP will continue investing in infrastructure and pursuing add-on acquisitions and partnerships nationwide.

Sheridan Capital Partners (“Sheridan”) announced today the formation of Ascend Plastic Surgery Partners (“Ascend” or the “Company”), a plastic surgery physician practice management company. Today, Ascend represents the combination of five plastic surgery practices and two standalone MedSpas. Sheridan invested alongside Ascend’s surgeons and management, who have retained a meaningful ownership stake in the business.

Sheridan Capital Partners (“Sheridan”) announced today the closing of its oversubscribed third buyout fund, Sheridan Capital Partners Fund III, LP and its parallel fund (collectively, “Fund III” or the “Fund”), at $575 million in aggregate commitments, exceeding its target of $450 million. Sheridan is focused on making investments in lower middle market companies in recession resistant, non-discretionary markets within the healthcare industry. The Fund will continue Sheridan’s strategy of making control investments in North American founder-owned businesses with $3-20 million of EBITDA.

Sheridan Capital Partners (Sheridan) announced today its investment in RS&A, LLC (“RSA”), an established medical device independent service provider (“ISP”) based out of Rural Hall, NC. Sheridan invested alongside RSA’s founding team, who retained a meaningful ownership stake in the business and will remain active in the operations of the Company.

Sheridan Capital Partners (“Sheridan”) is pleased to announce the sale of Dermatologists of Central States (“DOCS” or the “the Company”) to SkyKnight Capital (“SkyKnight”). Headquartered in Cincinnati and with a presence in seven states, DOCS is differentiated provider of management services to dermatology practices in the Midwest and Southeast United States.

Oral Surgery Partners (“OSP”), an established and rapidly-growing oral surgery group backed by Sheridan Capital Partners, announced today the completed partnerships with Oral and Facial Surgery Associates, West Texas Oral and Facial Surgery, William Paul DDS, Valley Oral & Facial Surgery, Show-Me Oral Surgery & Dental Implants, Piedmont Oral Surgery, and Summerville Oral Surgery. With these partnerships, OSP now provides services in seven states.

Sheridan Capital Partners (“Sheridan”) announced today its investment in SimiTree Healthcare Consulting (“SimiTree” or the “Company”), a strategic and equal combination of Simione Healthcare Consultants (“Simione”) and BlackTree Healthcare Consulting (“BlackTree”). SimiTree will help post-acute healthcare organizations achieve clinical and financial excellence through consulting, outsourcing, and talent solutions. Sheridan invested alongside SimiTree’s management team, who have retained meaningful ownership in the business.

Sheridan Capital Partners (Sheridan) announced today its investment in DAS Health Ventures, LLC (DAS Health), an established provider of healthcare IT management solutions and services. In the transaction, Sheridan invested alongside DAS Health’s management, who retained a meaningful ownership stake in the business. DAS Health actively serves nearly 2,000 clients and 20,000 users nationwide.

Sheridan Capital Partners (“Sheridan”) is pleased to announce the sale of Canadian Orthodontic Partners (“the Company”) to Pamlico Capital (“Pamlico”). Headquartered in Toronto and with a presence in 8 provinces, Canadian Orthodontic Partners is the largest provider of management services to orthodontic practices in Canada.